医药行业分析
- (2022-02-02)
- (2022-02-02)
- (2022-02-02)
- (2022-02-02)
- (2022-02-02)
- (2022-02-01)
- (2022-02-01)
- (2022-02-01)
- (2022-01-31)
- (2022-01-31)
- (2022-01-31)
- (2022-01-31)
- (2022-01-31)
- (2022-01-30)
- (2022-01-30)
- (2022-01-30)
- (2022-01-30)
- (2022-01-29)
- (2022-01-29)
- (2022-01-29)
- (2022-01-29)
- (2022-01-29)
- (2022-01-29)
- (2022-01-29)
- (2022-01-29)
- (2022-01-28)
- (2022-01-28)
- (2022-01-28)
- (2022-01-28)
- (2022-01-27)
- (2022-01-27)
- (2022-01-27)
- (2022-01-27)
- (2022-01-27)
- (2022-01-27)
- (2022-01-27)
- (2022-01-26)
- (2022-01-26)
- (2022-01-26)
- (2022-01-26)
- (2022-01-26)
- (2022-01-25)
- (2022-01-25)
- (2022-01-25)
- (2022-01-25)
- (2022-01-25)
- (2022-01-25)
- (2022-01-25)
- (2022-01-25)
- (2022-01-24)
- (2022-01-24)
- (2022-01-24)
- (2022-01-24)
- (2022-01-24)
- (2022-01-24)
- (2022-01-24)
- (2022-01-24)
- (2022-01-23)
- (2022-01-23)
HER2阳性结直肠癌(CRC)新药!阿斯利康/蔡威HER2靶向药物恩赫图:在HER2高表达的患者中 总缓解率为57.5%!
(2022-01-23)